UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Humoral Immune Response to Primary Rubella Virus Infection

Clinical and Vaccine Immunology, 2006-03, Vol.13 (3), p.380-386

2006

Volltextzugriff (PDF)

Iron and blood donation- an under-recognised safety issue

Developments in biologicals, 2007, Vol.127, p.137

Farrugia, A

2007

Volltextzugriff (PDF)

Clinicians as gatekeepers: what is the best route to optimal blood use?

Developments in biologicals, 2007, Vol.127, p.9

Isbister, J P

2007

Volltextzugriff (PDF)

Evolving approaches to estimate risks of transfusion-transmitted viral infections: incidence-window period model after ten years

Developments in biologicals, 2007, Vol.127, p.87

Busch, M R

2007

Volltextzugriff (PDF)

Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations

AIDS (London), 2004-11, Vol.18 (17), p.2253-2259

2004

Volltextzugriff (PDF)

Fitting new technologies into the safety paradigm: use of microarrays in transfusion

Developments in biologicals, 2007, Vol.127, p.61

2007

Volltextzugriff (PDF)

Safety and side-effects of buprenorphine in the clinical management of heroin addiction

Drug and alcohol dependence, 1990-08, Vol.26 (1), p.19-28

1990

Volltextzugriff (PDF)

Is haemovigilance improving transfusion practice?--The european experience

Developments in biologicals, 2007, Vol.127, p.215

Strengers, P F W

2007

Volltextzugriff (PDF)

The new Japanese blood law: its impact on blood safety and usage

Developments in biologicals, 2007, Vol.127, p.161

Tadokoro, K

2007

Volltextzugriff (PDF)

Advances in quality assurance of laboratory testing for transfusion safety

Developments in biologicals, 2007, Vol.127, p.183

2007

Volltextzugriff (PDF)

Emerging infections and global blood safety

Developments in biologicals, 2007, Vol.127, p.237

Dodd, R Y

2007

Volltextzugriff (PDF)

Reacting to an emerging safety threat: West Nile virus in North America

Developments in biologicals, 2007, Vol.127, p.43

Stramer, S L

2007

Volltextzugriff (PDF)

Parasitic infections in the blood supply: assessing and countering the threat

Developments in biologicals, 2007, Vol.127, p.17

2007

Volltextzugriff (PDF)

Characterization of scrapie-infected and normal hamster blood as an experimental model for TSE-infected human blood

Developments in biologicals, 2007, Vol.127, p.123

2007

Volltextzugriff (PDF)

The European Blood Directive--its role in blood safety

Developments in biologicals, 2007, Vol.127, p.147

Seitz, R

2007

Volltextzugriff (PDF)

The utility of multiplex NAT in blood screening

Developments in biologicals, 2007, Vol.127, p.71

2007

Volltextzugriff (PDF)

Value of HCV antigen-antibody combined HCV assay in hepatitis C diagnosis

Developments in biologicals, 2007, Vol.127, p.113

Lambert, N

2007

Volltextzugriff (PDF)

Nonoccupational post‐exposure prophylaxis source tracing: is it really feasible in Australia?

HIV medicine, 2012-08, Vol.13 (7), p.436-438

2012

Volltextzugriff (PDF)

Improved safety of clinical blood transfusion in four provinces of China 1997-2005

Developments in biologicals, 2007, Vol.127, p.197

Whyte, G

2007

Volltextzugriff (PDF)

Why do we believe in red cell transfusion?

Developments in biologicals, 2007, Vol.127, p.3

McClelland, B

2007

Volltextzugriff (PDF)

Blood safety--a focus on plasma derivatives in Mainland China

Developments in biologicals, 2007, Vol.127, p.175

Zhu, Y M

2007

Volltextzugriff (PDF)

Nonoccupational post‐exposure prophylaxis source tracing: is it really feasible in A ustralia?

HIV medicine, 2012-08, Vol.13 (7), p.436-438

2012

Volltextzugriff (PDF)

Domestic and imported products--the Malaysian experience in assuring safe and sufficient plasma products

Developments in biologicals, 2007, Vol.127, p.169

Ayob, Y

2007

Volltextzugriff (PDF)

Management of transfusion related risks: is risk communication to non-experts at all possible?

Developments in biologicals, 2007, Vol.127, p.249

Hossenlopp, C

2007

Volltextzugriff (PDF)

Commercial enzyme immunoassay adapted for the detection of antibodies to hepatitis C virus in dried blood spots

Journal of clinical virology, 2006-05, Vol.36 (1), p.68-71

2006

Volltextzugriff (PDF)

1 – 25 von 119

Menü

Weitere Dienste

Einstellungen

Humoral Immune Response to Primary Rubella Virus Infection

Iron and blood donation- an under-recognised safety issue

Clinicians as gatekeepers: what is the best route to optimal blood use?

Evolving approaches to estimate risks of transfusion-transmitted viral infections: incidence-window period model after ten years

Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations

Fitting new technologies into the safety paradigm: use of microarrays in transfusion

Safety and side-effects of buprenorphine in the clinical management of heroin addiction

Is haemovigilance improving transfusion practice?--The european experience

The new Japanese blood law: its impact on blood safety and usage

Advances in quality assurance of laboratory testing for transfusion safety

Emerging infections and global blood safety

Reacting to an emerging safety threat: West Nile virus in North America

Parasitic infections in the blood supply: assessing and countering the threat

Characterization of scrapie-infected and normal hamster blood as an experimental model for TSE-infected human blood

The European Blood Directive--its role in blood safety

The utility of multiplex NAT in blood screening

Value of HCV antigen-antibody combined HCV assay in hepatitis C diagnosis

Nonoccupational post‐exposure prophylaxis source tracing: is it really feasible in Australia?

Improved safety of clinical blood transfusion in four provinces of China 1997-2005

Why do we believe in red cell transfusion?

Blood safety--a focus on plasma derivatives in Mainland China

Nonoccupational post‐exposure prophylaxis source tracing: is it really feasible in A ustralia?

Domestic and imported products--the Malaysian experience in assuring safe and sufficient plasma products

Management of transfusion related risks: is risk communication to non-experts at all possible?

Commercial enzyme immunoassay adapted for the detection of antibodies to hepatitis C virus in dried blood spots

Suchergebnisse filtern